您当前的位置：
首页 >
文章列表页 >
Ditan Qingnao Formula for treating negative symptoms of schizophrenia with marrow-deficiency and phlegm-obscuring pattern: a randomized double-blind controlled trial
TCM Encephalopathy | 更新时间：2026-02-03

    • Ditan Qingnao Formula for treating negative symptoms of schizophrenia with marrow-deficiency and phlegm-obscuring pattern: a randomized double-blind controlled trial

    • “Experts from Beijing Huilongguan Hospital conducted a randomized double-blind placebo-controlled trial to verify the efficacy and safety of Ditan Qingnao Formula in treating negative symptoms of schizophrenia, providing a new treatment plan for schizophrenia.”
    • Journal of Beijing University of Traditional Chinese Medicine   Vol. 49, Issue 1, Pages: 95-105(2026)

    • DOI：10.3969/j.issn.1006-2157.2026.01.013    

      CLC： R277.7

    • Received：09 August 2025，

      Published：30 January 2026

    移动端阅览

  • ZHANG Yijie, ZHENG Junran, FANG Yilin, et al. Ditan Qingnao Formula for treating negative symptoms of schizophrenia with marrow-deficiency and phlegm-obscuring pattern: a randomized double-blind controlled trial[J]. Journal of Beijing University of Traditional Chinese Medicine, 2026, 49(1): 95-105. DOI： 10.3969/j.issn.1006-2157.2026.01.013.

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Exploring schizophrenia pathogenesis and treatment from the perspective of spirit, soul, and inferior spirit
Effect of disease duration on the efficacy of acupuncture for discogenic sciatica: a secondary analysis of a multicenter randomized controlled trial
Clinical study of Hewei Jiangni Formula in patients with non-erosive gastroesophageal reflux disease and cold-heat complex syndrome
Clinical study on the immediate and short-term therapeutic effects of Shexiang Tongxin Dripping Pill on improving coronary slow flow
Exploring the role and mechanism of Congrong Shujing Granules in regulating microglial polarization and inhibiting neuroinflammation based on the NLRP3/Caspase-1 signaling pathway

Related Author

WANG Yuling
XU Xiaonan
FANG Ting
XU Han
ZHOU Shuran
CUI Xiangning
WANG Jian
LI Binyan

Related Institution

中国中医科学院广安门医院 北京 100053Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
International Institute of Acupuncture and Moxibustion Innovation, Beijing University of Chinese Medicine
School of Acupuncture-moxibustion and Tuina, Beijing University of Chinese Medicine
Chongqing Hospital, the First Affiliated Hospital of Guangzhou University of Chinese Medicine
Dongfang Hospital, Beijing University of Chinese Medicine
0